Can a simple video and kit program help kids take their transplant meds?

NCT ID NCT07718204

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This study tests a program called MedMemos for families of children who have had a bone marrow transplant. The program includes four sessions with educational videos and a kit to help manage medications. Researchers want to see if families find it useful and if it helps them take their medicines as prescribed.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
MedMemos, a 4-session behavioral intervention with videos and a medication management kit
What this could lead to
If it works, MedMemos could become a standard tool to help families manage complex medication schedules after a bone marrow transplant, improving health outcomes.
What could go wrong
This is a small, early-stage trial focused on feasibility and acceptability, not yet on proving effectiveness. The results may not apply to all families or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC CELL TRANSPLANT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Bone Marrow Failure Disorders Infections Medication Adherence neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Nationwide Children's Hospital

    RECRUITING

    Columbus, Ohio, 43205, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.